1. Home
  2. TNXP vs HQI Comparison

TNXP vs HQI Comparison

Compare TNXP & HQI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tonix Pharmaceuticals Holding Corp.

TNXP

Tonix Pharmaceuticals Holding Corp.

N/A

Current Price

$9.26

Market Cap

199.7M

Sector

Health Care

ML Signal

N/A

Logo HireQuest Inc. (DE)

HQI

HireQuest Inc. (DE)

N/A

Current Price

$19.66

Market Cap

232.1M

ML Signal

N/A

Company Overview

Basic Information
Metric
TNXP
HQI
Founded
2007
2002
Country
United States
United States
Employees
N/A
75000
Industry
Biotechnology: Pharmaceutical Preparations
Professional Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
199.7M
232.1M
IPO Year
2008
2008

Fundamental Metrics

Financial Performance
Metric
TNXP
HQI
Price
$9.26
$19.66
Analyst Decision
Strong Buy
Buy
Analyst Count
3
2
Target Price
★ $44.50
$19.00
AVG Volume (30 Days)
★ 374.3K
20.4K
Earning Date
11-09-2026
11-05-2026
Dividend Yield
N/A
★ 1.25%
EPS Growth
★ 91.75
73.08
EPS
N/A
★ 0.31
Revenue
$13,107,000.00
★ $30,640,000.00
Revenue This Year
$319.65
$0.54
Revenue Next Year
$101.60
$5.47
P/E Ratio
★ N/A
$63.03
Revenue Growth
★ 29.85
N/A
52 Week Low
$9.40
$7.38
52 Week High
$24.64
$20.84

Technical Indicators

Market Signals
Indicator
TNXP
HQI
Relative Strength Index (RSI) 26.70 65.63
Support Level $9.40 $11.95
Resistance Level $12.99 N/A
Average True Range (ATR) 0.50 0.91
MACD -0.18 0.22
Stochastic Oscillator 3.73 66.68

Price Performance

Historical Comparison
TNXP
HQI

About TNXP Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Holding Corp is a fully-integrated biopharmaceutical company commercializing and developing therapies for central nervous system (CNS) disorders, immunology, infectious diseases, and rare diseases. Its portfolio consists of commercial, development and discovery-stage programs, TONMYA, an approved treatment for fibromyalgia, as well as marketed acute migraine products Zembrace SymTouch and Tosymra. The company is conducting clinical trials to evaluate TONMYA for additional indications such as depressive disorder and acute stress disorder. It is also advancing a pipeline of immunology programs, including monoclonal antibody TNX-4800 for Lyme disease prophylaxis and TNX-1500, a third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection.

About HQI HireQuest Inc. (DE)

HireQuest Inc is a nationwide franchisor of offices providing direct-dispatch, executive search, and commercial staffing solutions in the light industrial and blue-collar segments of the staffing industry and traditional commercial staffing. The company's franchisees provide various types of temporary personnel through two business models operating under the trade names HireQuest Direct, HireQuest, Snelling, DriverQuest, HireQuest Health, Northbound Executive Search, and MRI. The company's primary source of revenue is royalty fees based on the operation of its franchised offices.

Share on Social Networks: